PMID- 10523848 OWN - NLM STAT- MEDLINE DCOM- 19991122 LR - 20211203 IS - 0950-9232 (Print) IS - 0950-9232 (Linking) VI - 18 IP - 41 DP - 1999 Oct 7 TI - alphaPIX nucleotide exchange factor is activated by interaction with phosphatidylinositol 3-kinase. PG - 5680-90 AB - p21-activated kinase (PAK) is a common effector protein of the small GTPases Cdc42 and Rac, leading to the activation of downstream mitogen activated protein kinases. PAK also mediates polarized cytoskeletal changes induced by these GTPases. The recently identified PAK-interacting exchange factor (PIX) acts as a guanine nucleotide exchange factor on Rac, and colocalizes with PAK in a focal complex, but little is known about the associated signaling cascades, including upstream activators of PIX. In this study, we show that one of the isoforms of PIX, alphaPIX, is activated by signaling cascades from the platelet-derived growth factor (PDGF) receptor and EphB2 receptor, and from integrin-induced signaling through phosphatidylinositol 3-kinase (PI3-kinase). alphaPIX is activated by forming a complex with these receptors either via association with PAK and Nck, or direct association with the p85 regulatory subunit of PI3-kinase. Synthetic phosphoinositide and membrane targeted PI3-kinase augmented the alphaPIX activity in vivo. In Xenopus, aggregates of mesodermal cells derived from embryos microinjected with alphaPIX significantly increased the peripheral spreading on fibronectin substrate in response to PDGF through PI3-kinase. These results indicate that alphaPIX is activated by PI3-kinase, and is involved in the receptor mediated signaling leading to the activation of the kinase activity of PAK, and the migration of mesodermal cells on extracellular matrix. FAU - Yoshii, S AU - Yoshii S AD - The First Department of Pathology, Hamamatsu University School of Medicine, 3600 Handa-cho, Hamamatsu, 431-3192 Japan. FAU - Tanaka, M AU - Tanaka M FAU - Otsuki, Y AU - Otsuki Y FAU - Wang, D Y AU - Wang DY FAU - Guo, R J AU - Guo RJ FAU - Zhu, Y AU - Zhu Y FAU - Takeda, R AU - Takeda R FAU - Hanai, H AU - Hanai H FAU - Kaneko, E AU - Kaneko E FAU - Sugimura, H AU - Sugimura H LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Oncogene JT - Oncogene JID - 8711562 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Cell Cycle Proteins) RN - 0 (Fibronectins) RN - 0 (Guanine Nucleotide Exchange Factors) RN - 0 (Macromolecular Substances) RN - 0 (Nck protein) RN - 0 (Oncogene Proteins) RN - 0 (Protein Isoforms) RN - 0 (Rho Guanine Nucleotide Exchange Factors) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) RN - EC 2.7.10.1 (Receptor, EphB2) RN - EC 2.7.10.1 (Receptors, Platelet-Derived Growth Factor) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.1 (p21-Activated Kinases) RN - EC 3.6.1.- (GTP Phosphohydrolases) SB - IM MH - Adaptor Proteins, Signal Transducing MH - Animals MH - COS Cells MH - Cell Adhesion MH - Cell Cycle Proteins/*physiology MH - Cell Movement MH - Chlorocebus aethiops MH - Cytoskeleton/ultrastructure MH - Extracellular Matrix MH - Fibronectins MH - GTP Phosphohydrolases/physiology MH - *Guanine Nucleotide Exchange Factors MH - MAP Kinase Signaling System MH - Macromolecular Substances MH - Mesoderm/cytology MH - Microinjections MH - Models, Biological MH - Oncogene Proteins/physiology MH - Phosphatidylinositol 3-Kinases/*physiology MH - Phosphorylation MH - Protein Isoforms/*physiology MH - Protein Processing, Post-Translational MH - Protein Serine-Threonine Kinases/physiology MH - Receptor Protein-Tyrosine Kinases/physiology MH - Receptor, EphB2 MH - Receptors, Platelet-Derived Growth Factor/physiology MH - Rho Guanine Nucleotide Exchange Factors MH - Signal Transduction/*physiology MH - Xenopus laevis/embryology MH - p21-Activated Kinases MH - src Homology Domains EDAT- 1999/10/19 09:00 MHDA- 2000/10/18 11:01 CRDT- 1999/10/19 09:00 PHST- 1999/10/19 09:00 [pubmed] PHST- 2000/10/18 11:01 [medline] PHST- 1999/10/19 09:00 [entrez] AID - 10.1038/sj.onc.1202936 [doi] PST - ppublish SO - Oncogene. 1999 Oct 7;18(41):5680-90. doi: 10.1038/sj.onc.1202936.